Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis

Overview

Journal J Neuroimmune Pharmacol

Specialties Allergy & Immunology
Neurology
Pharmacology

Date 2010 Jan 29

PMID 20107924

Citations 109

Authors

Mohamed El-Behi

Abdolmohamad Rostami

Bogoljub Ciric

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are autoimmune demyelinating diseases of the central nervous system (CNS). Interferon-gamma-producing Th1 and interleukin-17-producing Th17 CD4(+) T helper (Th) cells mediate disease pathogenesis in EAE and likely in MS as well. However, the relative contribution of each Th subset to autoimmune processes in the CNS remains unclear. Emerging data suggest that both Th1 and Th17 cells contribute to CNS autoimmunity, albeit through different mechanisms. A better understanding of the roles that Th1 and Th17 cells play in autoimmune inflammation will be helpful in developing new therapeutic approaches. In this review, we discuss recent findings on the roles of Th1 and Th17 cells in the pathogenesis of EAE.

Citing Articles

Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis.

Vaitaitis G, Wagner Jr D Neurol Int. 2024; 16(6):1540-1551.

PMID: 39585073 PMC: 11587089. DOI: 10.3390/neurolint16060114.

Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation.

Lim J, Neuwirth A, Chung K, Grossklaus S, Soehnlein O, Hajishengallis G Front Immunol. 2024; 15:1354074.

PMID: 39148732 PMC: 11324504. DOI: 10.3389/fimmu.2024.1354074.

2-Bromo-1,4-Naphthalenedione promotes CD8 T cell expansion and limits Th1/Th17 to mitigate experimental autoimmune encephalomyelitis.

Yang C, Ma Y, Lu Q, Qu Y, Li Y, Cheng S J Neuroinflammation. 2024; 21(1):181.

PMID: 39068463 PMC: 11283727. DOI: 10.1186/s12974-024-03172-x.

Dietary protection against the visual and motor deficits induced by experimental autoimmune encephalomyelitis.

Zyla-Jackson K, Walton D, Plafker K, Kovats S, Georgescu C, Brush R Front Neurol. 2023; 14:1113954.

PMID: 36937529 PMC: 10017782. DOI: 10.3389/fneur.2023.1113954.

Transcriptional inhibition of STAT1 functions in the nucleus alleviates Th1 and Th17 cell-mediated inflammatory diseases.

Park J, Son M, Ho C, Lee S, Kim Y, An J Front Immunol. 2023; 13:1054472.

PMID: 36591260 PMC: 9800178. DOI: 10.3389/fimmu.2022.1054472.

References

OConnor Jr W, Kamanaka M, Booth C, Town T, Nakae S, Iwakura Y . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603-9. PMC: 2709990. DOI: 10.1038/ni.1736. View

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

Kuchroo V, Anderson A, Waldner H, Munder M, Bettelli E, Nicholson L . T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol. 2002; 20:101-23. DOI: 10.1146/annurev.immunol.20.081701.141316. View

Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6(11):1133-41. PMC: 1618871. DOI: 10.1038/ni1261. View

Gran B, Zhang G, Yu S, Li J, Chen X, Ventura E . IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol. 2002; 169(12):7104-10. DOI: 10.4049/jimmunol.169.12.7104. View

Cua D, Sherlock J, Chen Y, Murphy C, Joyce B, Seymour B . Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003; 421(6924):744-8. DOI: 10.1038/nature01355. View

Gyulveszi G, Haak S, Becher B . IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur J Immunol. 2009; 39(7):1864-9. DOI: 10.1002/eji.200939305. View

Muller M, Carter S, Hofer M, Manders P, Getts D, Getts M . CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol. 2007; 179(5):2774-86. DOI: 10.4049/jimmunol.179.5.2774. View

Kroenke M, Carlson T, Andjelkovic A, Segal B . IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008; 205(7):1535-41. PMC: 2442630. DOI: 10.1084/jem.20080159. View

10.

Bettelli E, Sullivan B, Szabo S, Sobel R, Glimcher L, Kuchroo V . Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med. 2004; 200(1):79-87. PMC: 2213316. DOI: 10.1084/jem.20031819. View

11.

Mosmann T, Coffman R . TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989; 7:145-73. DOI: 10.1146/annurev.iy.07.040189.001045. View

12.

Bending D, De La Pena H, Veldhoen M, Phillips J, Uyttenhove C, Stockinger B . Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest. 2009; 119(3):565-72. PMC: 2648686. DOI: 10.1172/JCI37865. View

13.

Stockinger B, Veldhoen M . Differentiation and function of Th17 T cells. Curr Opin Immunol. 2007; 19(3):281-6. DOI: 10.1016/j.coi.2007.04.005. View

14.

Awasthi A, Riol-Blanco L, Jager A, Korn T, Pot C, Galileos G . Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol. 2009; 182(10):5904-8. PMC: 2702203. DOI: 10.4049/jimmunol.0900732. View

15.

Lees J, Iwakura Y, Russell J . Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J Immunol. 2008; 180(12):8066-72. DOI: 10.4049/jimmunol.180.12.8066. View

16.

Ciric B, El-Behi M, Cabrera R, Zhang G, Rostami A . IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol. 2009; 182(9):5296-305. DOI: 10.4049/jimmunol.0900036. View

17.

Stritesky G, Yeh N, Kaplan M . IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol. 2008; 181(9):5948-55. PMC: 2678905. DOI: 10.4049/jimmunol.181.9.5948. View

18.

Yamazaki T, Yang X, Chung Y, Fukunaga A, Nurieva R, Pappu B . CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol. 2008; 181(12):8391-401. PMC: 2752441. DOI: 10.4049/jimmunol.181.12.8391. View

19.

Elhofy A, DePaolo R, Lira S, Lukacs N, Karpus W . Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. J Neuroimmunol. 2009; 213(1-2):91-9. PMC: 2728039. DOI: 10.1016/j.jneuroim.2009.05.011. View

20.

Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martinez-A C . CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur J Immunol. 2009; 39(6):1671-81. DOI: 10.1002/eji.200839123. View